8-K/A

AMENDED CURRENT REPORT

Company: AYTU BIOPHARMA, INC
Filed: November 4, 2019
Period of Report: October 31, 2019
Accession Number: 0001654954-19-012347

View Document ↗ View on SEC.gov ↗